356 related articles for article (PubMed ID: 19544546)
1. Genomic approaches to outcome prediction in prostate cancer.
Febbo PG
Cancer; 2009 Jul; 115(13 Suppl):3046-57. PubMed ID: 19544546
[TBL] [Abstract][Full Text] [Related]
2. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
Nguyen CT; Kattan MW
Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer and the genomic revolution: Advances using microarray analyses.
Calvo A; Gonzalez-Moreno O; Yoon CY; Huh JI; Desai K; Nguyen QT; Green JE
Mutat Res; 2005 Aug; 576(1-2):66-79. PubMed ID: 15950992
[TBL] [Abstract][Full Text] [Related]
4. Biomolecular markers of outcome prediction in prostate cancer.
Lopergolo A; Zaffaroni N
Cancer; 2009 Jul; 115(13 Suppl):3058-67. PubMed ID: 19544547
[TBL] [Abstract][Full Text] [Related]
5. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
6. Genomic signatures associated with the development, progression, and outcome of prostate cancer.
Mendiratta P; Febbo PG
Mol Diagn Ther; 2007; 11(6):345-54. PubMed ID: 18078352
[TBL] [Abstract][Full Text] [Related]
7. High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.
Ishkanian AS; Mallof CA; Ho J; Meng A; Albert M; Syed A; van der Kwast T; Milosevic M; Yoshimoto M; Squire JA; Lam WL; Bristow RG
Prostate; 2009 Jul; 69(10):1091-100. PubMed ID: 19350549
[TBL] [Abstract][Full Text] [Related]
8. Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
Watson SK; Woolcock BW; Fee JN; Bainbridge TC; Webber D; Kinahan TJ; Lam WL; Vielkind JR
Prostate; 2009 Jun; 69(9):961-75. PubMed ID: 19267368
[TBL] [Abstract][Full Text] [Related]
9. Oncogenomics: prospects for the future.
Sakatani T; Onyango P
Expert Rev Anticancer Ther; 2003 Dec; 3(6):891-901. PubMed ID: 14686710
[TBL] [Abstract][Full Text] [Related]
10. Molecular changes in prostatic cancer.
Bott SR; Arya M; Shergill IS; Williamson M
Surg Oncol; 2005 Aug; 14(2):91-104. PubMed ID: 15993579
[TBL] [Abstract][Full Text] [Related]
11. Different approaches of gene therapy used in prostate cancer.
Ghosh A
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):103-11. PubMed ID: 16171569
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: genes, environment, immunity and the use of immunotherapy.
Karan D; Thrasher JB; Lubaroff D
Prostate Cancer Prostatic Dis; 2008; 11(3):230-6. PubMed ID: 18283297
[TBL] [Abstract][Full Text] [Related]
13. Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.
Valdagni R; Rancati T; Fiorino C
Cancer; 2009 Jul; 115(13 Suppl):3141-9. PubMed ID: 19544543
[TBL] [Abstract][Full Text] [Related]
14. Molecular alterations in prostate cancer.
Reynolds MA
Cancer Lett; 2008 Nov; 271(1):13-24. PubMed ID: 18554779
[TBL] [Abstract][Full Text] [Related]
15. Techniques and predictive models to improve prostate cancer detection.
Herman MP; Dorsey P; John M; Patel N; Leung R; Tewari A
Cancer; 2009 Jul; 115(13 Suppl):3085-99. PubMed ID: 19544550
[TBL] [Abstract][Full Text] [Related]
16. Predictive modeling in prostate cancer. Conclusions and reflections.
Denis LJ; Gospodarowicz MK
Cancer; 2009 Jul; 115(13 Suppl):3160-2. PubMed ID: 19544535
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of microarray-derived genetic signatures in predicting outcomes in prostate cancer.
Reddy GK; Balk SP
Clin Genitourin Cancer; 2006 Dec; 5(3):187-9. PubMed ID: 17239271
[TBL] [Abstract][Full Text] [Related]
18. Prostate carcinogenesis and inflammation: emerging insights.
Palapattu GS; Sutcliffe S; Bastian PJ; Platz EA; De Marzo AM; Isaacs WB; Nelson WG
Carcinogenesis; 2005 Jul; 26(7):1170-81. PubMed ID: 15498784
[TBL] [Abstract][Full Text] [Related]
19. The 2008 European School of Oncology inside track conference, "predictive modeling in prostate cancer".
Valdagni R; Scardino PT; Denis L
Cancer; 2009 Jul; 115(13 Suppl):3035-8. PubMed ID: 19544554
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers in the diagnosis of prostate cancer.
van der Poel HG
Crit Rev Oncol Hematol; 2007 Feb; 61(2):104-39. PubMed ID: 16945550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
